G. Lukina

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration

Kim Lauper, Michele Iudici, Denis Mongin et al. · Annals of the Rheumatic Diseases · 2022 · 138 citations · Full text

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Delphine S. Courvoisier, Katerina Chatzidionysiou, Denis Mongin et al. · Lara D. Veeken · 2020 · 90 citations

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Katerina Chatzidionysiou, Elisabeth Lie, E L Nasonov et al. · Annals of the Rheumatic Diseases · 2011 · 76 citations · Full text

Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study

Cem Gabay, Myriam Riek, Merete Lund Hetland et al. · Annals of the Rheumatic Diseases · 2015 · 70 citations · Full text

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration

Kim Lauper, Dan Nordström, Karel Pavelká et al. · Annals of the Rheumatic Diseases · 2018 · 70 citations · Full text